Januvia May Cause Pancreatic Cancer and Death, Lawsuits Allege

Last Updated on June 26, 2017

Important Information

Attorneys working with ClassAction.org are no longer investigating this matter. The information here is for reference only. A list of open investigations and lawsuits can be viewed here.

Comments |

At A Glance

This Alert Affects
Those who were diagnosed with pancreatic cancer after taking Januvia (sitagliptin) or Janumet (sitagliptin/metformin).
What Is Januvia?
Januvia is used to treat type 2 diabetes and belongs to a group of drugs known as incretin mimetics. It is also available as a combination drug, known as Janumet, which contains both Januvia and another type 2 diabetes drug, metformin.
Side Effects
Pancreatitis, pancreatic cancer and death.
Merck & Co., Inc.
Type of Lawsuit
Mass Tort